Banner: Taking BENLYSTA — Taking BENLYSTA

Stephanie

Real patient
compensated by GSK

In a clinical study in Black patients with lupus, a reduction in disease activity was seen but was not statistically significant. Ask your doctor about BENLYSTA.

Whether you have lupus or active lupus nephritis, with BENLYSTA you have a choice.

There are two ways to take BENLYSTA:

Self-injection at home: for adults with lupus and/or lupus nephritis
Intravenous infusion administered by a healthcare provider: for adults with lupus and/or lupus nephritis and for children with lupus (aged 5-17 years)

Ask your doctor which BENLYSTA option is right for you.

Subcutaneous (SC) Use (BENLYSTA Injection)

At-home administration
After being trained by a healthcare provider, you can self-inject BENLYSTA from the comfort of your own home with a once-weekly subcutaneous injection.

Learn more

Intravenous (IV) Use (BENLYSTA Infusion)

In-office administration

When beginning treatment with BENLYSTA IV, it is recommended that you receive infusions from a healthcare provider every 2 weeks for the first 3 doses, and every 4 weeks thereafter. Infusions are usually given at a doctor’s office or an infusion center.

Learn more

Your overview of BENLYSTA Dosing Options

Dosing for SC in adult patients: At-home administration

* The 400-mg dose requires administration of 2 autoinjectors (2 x 200 mg). When the 400-mg dose is administered at the same site, it is recommended that the 2 individual 200-mg injections be administered at least 5 cm (approximately 2 inches) apart.

Dosing for IV: In-office administration

Did you know? In a small survey with adult patients with lupus who switched from receiving BENLYSTA via IV infusion to the BENLYSTA autoinjector, 3 out of 4 preferred the autoinjector. Your experience may be different.

Frequently Asked Questions

Expand All Collapse All

I’m currently receiving monthly BENLYSTA IV infusions. Can I switch to the autoinjector?

You may be a candidate for BENLYSTA at-home administration with the autoinjector. Talk to your doctor to see if switching to the BENLYSTA autoinjector is right for you.

If you and your doctor decide that you should switch, BENLYSTA Gateway is there to help you through the process.

Was this helpful?

Yes, it was helpful.

No, it was not helpful.
What is the BENLYSTA Co-pay Program?

Pay as little as $0 for BENLYSTA.*

The BENLYSTA Co-pay Program helps eligible commercially insured patients with their out-of-pocket costs for BENLYSTA up to $15,000 for 12 months.

*Eligibility restrictions and program maximums apply. Visit www.GSKCopayPrograms.com for complete Program Terms and Conditions.

To learn more, call 1-877-4-BENLYSTA (1-877-423-6597) from 8 AM to 8 PM Eastern Time, Monday through Friday.

Was this helpful?

Yes, it was helpful.

No, it was not helpful.
Can I take BENLYSTA if I am pregnant or plan to become pregnant?

Before you receive BENLYSTA, tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least 4 months after the final dose of BENLYSTA. Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.

Was this helpful?

Yes, it was helpful.

No, it was not helpful.

Want to learn more about resources for BENLYSTA?

Whether you are just getting started with BENLYSTA, or have been taking BENLYSTA for a while, BENLYSTA Cares offers support and ongoing resources throughout the course of your treatment.

Discover the BENLYSTA experience

Hear from real patients about their experiences living with lupus and with BENLYSTA treatment.

DISCOVER BENLYSTA FROM THEIR PERSPECTIVE

What is BENLYSTA?

Important Safety Information

What is BENLYSTA & Safety Info

For patients ≥5 years with active SLE (lupus) or adults with active lupus nephritis on other lupus medicines. Unknown if safe/effective with severe active central nervous system lupus. Don't use if allergic to any ingredients in BENLYSTA. Serious side effects may include death. Tell your doctor right away if… [Continue reading...]

BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

${body_floating_mobile_right}

Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.

The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.

Important Safety Information

Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.

The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.

Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death.
Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.

Before receiving BENLYSTA also discuss with your healthcare provider if you:

think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
have or have had mental health problems such as depression or thoughts of suicide.
have recently received a vaccination or if you think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
are allergic to other medicines.
are receiving other biologic medicines or monoclonal antibodies.
have or have had any type of cancer.
have any other medical conditions.
are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least 4 months after the final dose of BENLYSTA.
Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.
become pregnant while receiving BENLYSTA. Talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should talk about whether or not you should receive BENLYSTA and breastfeed.

Possible side effects of BENLYSTA

Progressive multifocal leukoencephalopathy (PML). PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

Please see Prescribing Information and Medication Guide for BENLYSTA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088

Have questions or need assistance?

Call 1-877-4-BENLYSTA (1-877-423-6597)

Insured

Underinsured

Uninsured

Whether you are insured, underinsured, or uninsured, BENLYSTA Cares and our team at BENLYSTA Gateway may be able to help.

Trademarks are owned by or licensed to the GSK group of companies.

This website is funded and developed by GSK
This site is intended for US residents only
©2020 GSK or licensor.
BELWCNT210054 September 2021
Produced in USA.

Taking BENLYSTA

Stephanie

Real patient compensated by GSK